Arcturus Therapeutics Holdings Inc. (ARCT) vs Assembly Biosciences, Inc. (ASMB)
A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and Assembly Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARCT
Arcturus Therapeutics Holdings Inc.
$14.66HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ASMB
Assembly Biosciences, Inc.
$22.74HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ARCT vs ASMB
growth of $100 · dividends reinvested · last 10yARCT -19.5% (-2.1%/yr)ASMB -76.4% (-13.4%/yr)ARCT compounded faster over this window
ARCT ASMB
ARCT vs ASMB: by the numbers
- •ASMB is the larger company ($451M vs $417M market cap).
- •Both run net losses; ASMB's is the smaller (-0.06% vs -391.90% net margin).
- •ARCT grew revenue faster over the past five years (22.30% vs -1.78% CAGR).
Metrics side by side
Valuation
| Metric | ARCT | ASMB |
|---|---|---|
| P/E ratio | N/A | 41.35 |
| P/S ratio | 17.51 | 6.02 |
| P/B ratio | 2.43 | 1.47 |
Profitability
| Metric | ARCT | ASMB |
|---|---|---|
| Gross margin | 95.50% | 99.82% |
| Operating margin | -111.51% | -11.75% |
| Net margin | -391.90% | -0.06% |
| ROE | -54.29% | -0.01% |
| ROIC | -54.07% | -2.86% |
Growth (annualized)
| Metric | ARCT | ASMB |
|---|---|---|
| Revenue CAGR (5Y) | 22.30% | -1.78% |
| Total return CAGR (5Y) | -18.73% | -10.66% |
Frequently asked
- Which has grown faster, ARCT or ASMB?
- Over the past five years, ARCT grew revenue faster — ARCT at a 22.30% CAGR versus ASMB at -1.78%.
- How have ARCT and ASMB total returns compared?
- Over the past 10 years, ARCT delivered -2.54% and ASMB delivered -13.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Assembly Biosciences P/E ratioArcturus Therapeutics ROEAssembly Biosciences ROEArcturus Therapeutics operating marginAssembly Biosciences operating marginArcturus Therapeutics revenue growthAssembly Biosciences revenue growthArcturus Therapeutics free cash flowAssembly Biosciences free cash flow
Arcturus Therapeutics & Assembly Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.